BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240325
DTEND;VALUE=DATE:20240328
DTSTAMP:20260516T003800
CREATED:20231115T103534Z
LAST-MODIFIED:20231115T103534Z
UID:38132-1711324800-1711583999@www.pharmajournalist.com
SUMMARY:6th Neuroimmunology Drug Development Summit
DESCRIPTION:Neuroimmunology targets in neurodegeneration are hotter than ever. Capturing biopharma’s latest research spanning discovery to early clinical development\, the 6th Neuroimmunology Drug Development Summit is the industry-choice\, comprehensive forum dedicated to translating neuroinflammatory-targeted therapeutics into clinical trials. \nWhat are the top features to look forward to in 2024? \n\nDoubled pre-conference workshop content\, with 6 deep-dive sessions tailored to your discovery biology and translational expertise led by neuroimmunology leaders from Lundbeck\, Sanofi\, Merck\, Regeneron\, and more\nAgenda content spotlighted neurodegeneration – including TREM2 clinical data updates and breaking down trial design and rationale with Alector and Vigil Neuroscience\nNew case studies beyond microglia\, with sessions spearheading astrocyte function and therapeutic intervention from Sanofi\, IMNEWRUN\, and UCL\nBrand-new content on immunocompetent brain organoids to recapitulate and investigate complex neuroimmune interactions with Roche and Herophilus\nIt is the biggest and most comprehensive program to date\, with 38+ industry and academic speakers\, including new presenting companies Eisai\, EMD Serono\, Ventus Therapeutics\, PTC Therapeutics\, and Inflammasome Therapeutics\n\nUniting 100+ all-star leaders across industry and academia\, this is the must-attend forum for anyone working on treatments targeting neuroinflammation across neurological indications and looking to accelerate their candidates into the clinic in 2024. \nTo know more visit: https://ter.li/wb3bhh
URL:http://www.pharmajournalist.com/event/6th-neuroimmunology-drug-development-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240325
DTEND;VALUE=DATE:20240328
DTSTAMP:20260516T003800
CREATED:20231120T150249Z
LAST-MODIFIED:20231120T150249Z
UID:38186-1711324800-1711583999@www.pharmajournalist.com
SUMMARY:5th Supply Chain & Logistics for Cell Therapies Summit
DESCRIPTION:As the cell therapy field rapidly expands\, keeping ahead of the race by creating a visible and robust supply chain has never been more critical to ensure you have the skills and strategy to develop into the next stage of your pipeline. \nJoin us at the 5th Supply Chain & Logistics for Cell Therapies Summit in Boston from March 25-27th. This summit will bring together logistics and clinical operations experts to establish standardized best practices in planning\, communication and assist companies in scaling up to consistently deliver cell therapies safely\, on time\, and in a cost-effective process. \nSeize the opportunity to enhance your expertise in cell therapy logistics by connecting with leaders in clinical operations\, including esteemed companies like Beam Therapeutics\, Lovance\, Arcellx\, Jassen Pharmaceuticals\, and more. \nDownload the event guide to learn more: https://ter.li/d6jto3
URL:http://www.pharmajournalist.com/event/5th-supply-chain-logistics-for-cell-therapies-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR